Slate Path Capital LP - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 63 filers reported holding CUE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Slate Path Capital LP ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$5,525,647
-37.0%
2,402,4550.0%0.15%
-52.0%
Q2 2023$8,768,961
+2.2%
2,402,4550.0%0.32%
-20.3%
Q1 2023$8,576,764
+25.3%
2,402,4550.0%0.40%
+9.5%
Q4 2022$6,846,997
+107.0%
2,402,455
+61.9%
0.37%
+71.2%
Q3 2022$3,308,000
-10.4%
1,483,6190.0%0.22%
-6.9%
Q2 2022$3,694,000
-49.0%
1,483,6190.0%0.23%
-37.7%
Q1 2022$7,240,000
-56.9%
1,483,6190.0%0.37%
-57.8%
Q4 2021$16,780,000
-22.4%
1,483,6190.0%0.88%
-10.9%
Q3 2021$21,616,000
+25.1%
1,483,6190.0%0.99%
+2.2%
Q2 2021$17,284,000
-4.5%
1,483,6190.0%0.96%
-17.8%
Q1 2021$18,100,000
-2.5%
1,483,6190.0%1.17%
+16.9%
Q4 2020$18,560,000
-16.9%
1,483,6190.0%1.00%
-20.9%
Q3 2020$22,328,000
+4.6%
1,483,619
+70.4%
1.27%
+0.9%
Q2 2020$21,341,000
+72.7%
870,6940.0%1.26%
+32.8%
Q1 2020$12,355,000
-12.6%
870,694
-2.2%
0.95%
+24.6%
Q4 2019$14,129,000
+88.3%
890,0000.0%0.76%
+53.1%
Q3 2019$7,503,000890,0000.50%
Other shareholders
CUE BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Prosight Management, LP 1,545,573$3,447,0001.85%
P.A.W. CAPITAL CORP 200,000$446,0000.67%
SANDERS MORRIS HARRIS LLC 848,048$2,020,0000.50%
Monaco Asset Management SAM 458,851$1,023,0000.39%
Bleichroeder LP 555,000$1,238,0000.26%
APOGEM CAPITAL LLC 110,614$247,0000.25%
Slate Path Capital LP 1,483,619$3,308,0000.22%
Voss Capital, LLC 200,000$446,0000.13%
Robertson Stephens Wealth Management, LLC 478,500$1,067,0000.11%
CARLSON CAPITAL L P 535,000$1,193,0000.09%
View complete list of CUE BIOPHARMA INC shareholders